Literature DB >> 8005104

Expression of syndecan-1 is induced by differentiation and suppressed by malignant transformation of human keratinocytes.

P Inki1, H Larjava, K Haapasalmi, H M Miettinen, R Grenman, M Jalkanen.   

Abstract

Syndecans comprise a family of integral membrane proteoglycans that presumably participate in cell-matrix interactions and the modulation of growth factor response. Expression of syndecan-1, a cell surface proteoglycan that binds basic fibroblast growth factor (bFGF) and extracellular matrix components, was studied in cultured human keratinocytes from the oral mucosa and in tissue sections derived from various epithelia and carcinomas of the head and neck. For the study, polyclonal antibodies were raised against the core protein of human syndecan-1. The affinity-purified antibody (designated anti-P117) was shown to react specifically with syndecan-1. Abundant expression of syndecan-1 was detected in frozen sections of various stratified epithelia as well as in cultured keratinocytes. Keratinocytes located in the spinous cell layers showed intense immunoreactivity for syndecan-1, while basal cells stained rather weakly, suggesting that the expression of syndecan-1 could be stimulated during the differentiation of keratinocytes. Cultured human keratinocytes were induced to terminally differentiate by increasing the extracellular calcium concentration of the medium. Parallel to the induction of involucrin expression, the mRNA levels of syndecan-1 were found to increase, suggesting that syndecan-1 is indeed induced during keratinocyte differentiation. The molecular mass and glycosaminoglycan composition of syndecan-1 did not change markedly during calcium-induced differentiation. Malignant transformation was associated with marked reduction of syndecan-1 expression, based on the immunoreactivity of anti-P117 in frozen sections from squamous cell carcinomas (SCCs) of the head and neck.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8005104

Source DB:  PubMed          Journal:  Eur J Cell Biol        ISSN: 0171-9335            Impact factor:   4.492


  11 in total

1.  Loss of cell surface syndecan-1 causes epithelia to transform into anchorage-independent mesenchyme-like cells.

Authors:  M Kato; S Saunders; H Nguyen; M Bernfield
Journal:  Mol Biol Cell       Date:  1995-05       Impact factor: 4.138

2.  Activation of an enhancer on the syndecan-1 gene is restricted to fibroblast growth factor family members in mesenchymal cells.

Authors:  P Jaakkola; T Vihinen; A Määttä; M Jalkanen
Journal:  Mol Cell Biol       Date:  1997-06       Impact factor: 4.272

Review 3.  Antithetic roles of proteoglycans in cancer.

Authors:  Elena Garusi; Silvia Rossi; Roberto Perris
Journal:  Cell Mol Life Sci       Date:  2011-10-02       Impact factor: 9.261

4.  Syndecan-1 - A new piece in B-cell puzzle.

Authors:  L Kopper; A Sebestyén; M Gallai; I Kovalszky
Journal:  Pathol Oncol Res       Date:  1997-09       Impact factor: 3.201

5.  Different heparan sulfate proteoglycans serve as cellular receptors for human papillomaviruses.

Authors:  Saeed Shafti-Keramat; Alessandra Handisurya; Ernst Kriehuber; Guerrino Meneguzzi; Katharina Slupetzky; Reinhard Kirnbauer
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

6.  Syndecan-1 alterations during the tumorigenic progression of human colonic Caco-2 cells induced by human Ha-ras or polyoma middle T oncogenes.

Authors:  P Levy; A Munier; S Baron-Delage; Y Di Gioia; C Gespach; J Capeau; G Cherqui
Journal:  Br J Cancer       Date:  1996-08       Impact factor: 7.640

7.  Proteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/CSPG4 and syndecan-2 as unique relapse and overall survival predicting factors.

Authors:  Anna Farnedi; Silvia Rossi; Nicoletta Bertani; Mariolina Gulli; Enrico Maria Silini; Maria Teresa Mucignat; Tito Poli; Enrico Sesenna; Davide Lanfranco; Lucio Montebugnoli; Elisa Leonardi; Claudio Marchetti; Renato Cocchi; Andrea Ambrosini-Spaltro; Maria Pia Foschini; Roberto Perris
Journal:  BMC Cancer       Date:  2015-05-03       Impact factor: 4.430

8.  Comparison of Syndecan-1 Immunohistochemical Expression in Lobular and Ductal Breast Carcinoma with Nodal Metastases.

Authors:  Ivana Miše; Majda Vučić
Journal:  Anal Cell Pathol (Amst)       Date:  2018-07-29       Impact factor: 2.916

9.  Association between syndecan-1 expression and clinical outcome in squamous cell carcinoma of the head and neck.

Authors:  P Inki; H Joensuu; R Grénman; P Klemi; M Jalkanen
Journal:  Br J Cancer       Date:  1994-08       Impact factor: 7.640

10.  The expression of syndecan-1 in psoriatic epidermis.

Authors:  Davor Tomas; Majda Vucić; Mirna Situm; Bozo Kruslin
Journal:  Arch Dermatol Res       Date:  2008-04-02       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.